BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

530697

ZENLABS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Zenlabs Ethica Limited Share Price Update

As of the latest trading session, Zenlabs Ethica Limited share price is currently at ₹ 31.39, which is down by ₹ -1.29 from its previous closing. Today, the stock has fluctuated between ₹ 31.06 and ₹ 33.40. Over the past year, Zenlabs Ethica Limited has achieved a return of -29.21 %. In the last month alone, the return has been 2.96 %. Read More...

Zenlabs Ethica Limited fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    20.40

  • P/E Ratio (TTM)

    61.55

  • Beta

    0.66

  • Book Value / share

    15.76

  • Return on equity

    4.24%

  • EPS (TTM)

    0.51

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.09

info icon alternate text

Zenlabs Ethica Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 12.72
Operating Expense 12.60
Net Profit 0.09
Net Profit Margin (%) 0.70
Earnings Per Share (EPS) 0.13
EBITDA 0.69
Effective Tax Rate (%) 30.76
Particulars SEP 2024 (Values in Cr)
Revenue 13.35
Operating Expense 13.28
Net Profit 0.05
Net Profit Margin (%) 0.37
Earnings Per Share (EPS) 0.08
EBITDA 0.62
Effective Tax Rate (%) 25.00
Particulars JUN 2024 (Values in Cr)
Revenue 12.36
Operating Expense 12.30
Net Profit 0.04
Net Profit Margin (%) 0.32
Earnings Per Share (EPS) 0.06
EBITDA 0.62
Effective Tax Rate (%) 42.85
Particulars MAR 2024 (Values in Cr)
Revenue 15.33
Operating Expense 15.14
Net Profit 0.15
Net Profit Margin (%) 0.97
Earnings Per Share (EPS) 0.23
EBITDA 0.79
Effective Tax Rate (%) 28.57
Particulars DEC 2023 (Values in Cr)
Revenue 15.60
Operating Expense 15.45
Net Profit 0.11
Net Profit Margin (%) 0.70
Earnings Per Share (EPS) 0.18
EBITDA 0.69
Effective Tax Rate (%) 26.66
Particulars MAR 2024 (Values in Cr)
Revenue 58.56
Operating Expense 58.28
Net Profit 0.42
Net Profit Margin (%) 0.71
Earnings Per Share (EPS) 0.65
EBITDA 2.70
Effective Tax Rate (%) 27.58
Particulars MAR 2023 (Values in Cr)
Revenue 66.89
Operating Expense 65.76
Net Profit 0.49
Net Profit Margin (%) 0.73
Earnings Per Share (EPS) 0.75
EBITDA 2.45
Effective Tax Rate (%) 28.35
Particulars MAR 2022 (Values in Cr)
Revenue 69.09
Operating Expense 67.91
Net Profit 0.82
Net Profit Margin (%) 1.18
Earnings Per Share (EPS) 1.26
EBITDA 2.52
Effective Tax Rate (%) 34.92
Particulars MAR 2021 (Values in Cr)
Revenue 56.64
Operating Expense 55.83
Net Profit 0.83
Net Profit Margin (%) 1.46
Earnings Per Share (EPS) 1.41
EBITDA 1.23
Effective Tax Rate (%) 9.78
Particulars MAR 2020 (Values in Cr)
Revenue 59.95
Operating Expense 61.17
Net Profit -0.73
Net Profit Margin (%) -1.21
Earnings Per Share (EPS) -1.33
EBITDA -0.79
Effective Tax Rate (%) 37.60
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.55
ROE % 4.24
ROCE % 6.51
Total Debt to Total Equity 1.04
EBITDA Margin 4.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.91
ROE % 9.44
ROCE % 11.75
Total Debt to Total Equity 0.51
EBITDA Margin 4.54
Particulars MAR 2022 (Values in Cr)
Book Value / Share 14.40
ROE % 9.15
ROCE % 13.01
Total Debt to Total Equity 0.36
EBITDA Margin 3.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.16
ROE % 9.64
ROCE % 11.52
Total Debt to Total Equity 0.21
EBITDA Margin 3.28
Particulars MAR 2020 (Values in Cr)
Book Value / Share 11.38
ROE % -9.31
ROCE % -10.66
Total Debt to Total Equity 0.08
EBITDA Margin -1.08
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.92
Total Assets 40.25
Total Liabilities 40.25
Total Equity 10.12
Share Outstanding 6510015
Price to Book Ratio 2.67
Return on Assets (%) 1.04
Return on Capital (%) 1.82
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.63
Total Assets 43.49
Total Liabilities 43.49
Total Equity 9.70
Share Outstanding 6510015
Price to Book Ratio 4.63
Return on Assets (%) 1.12
Return on Capital (%) 3.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 37.89
Total Liabilities 37.89
Total Equity 9.37
Share Outstanding 6510015
Price to Book Ratio 1.98
Return on Assets (%) 2.17
Return on Capital (%) 7.66
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.69
Total Assets 32.20
Total Liabilities 32.20
Total Equity 8.56
Share Outstanding 6510015
Price to Book Ratio 1.61
Return on Assets (%) 2.38
Return on Capital (%) 8.58
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.09
Total Assets 33.99
Total Liabilities 33.99
Total Equity 7.41
Share Outstanding 6510015
Price to Book Ratio 3.20
Return on Assets (%) -2.15
Return on Capital (%) -9.47
Particulars MAR 2024 (Values in Cr)
Net Income 0.58
Cash from Operations -8.91
Cash from Investing 0.10
Cash from Financing 8.23
Net change in Cash -0.71
Free Cash Flow -8.89
Particulars MAR 2023 (Values in Cr)
Net Income 0.67
Cash from Operations 1.78
Cash from Investing -1.46
Cash from Financing 0.06
Net change in Cash 0.11
Free Cash Flow 3.33
Particulars MAR 2022 (Values in Cr)
Net Income 1.26
Cash from Operations -0.25
Cash from Investing 0.00
Cash from Financing 0.31
Net change in Cash -0.06
Free Cash Flow -0.22
Particulars MAR 2021 (Values in Cr)
Net Income 0.86
Cash from Operations -8.31
Cash from Investing 0.15
Cash from Financing -0.52
Net change in Cash -8.78
Free Cash Flow -8.31
Particulars MAR 2020 (Values in Cr)
Net Income -1.16
Cash from Operations 0.45
Cash from Investing 0.00
Cash from Financing -0.03
Net change in Cash 0.42
Free Cash Flow 0.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 790.90 48.02 6.73 27760.59 574.70 / 1035.70
KOTHARI INDUSTRIAL CORPORATION 276.45 49.63 18.29 2147.57 3.82 / 276.45
MYSORE PETRO CHEMICALS LTD. 122.85 6.28 0.35 80.88 117.45 / 261.90
OSWAL AGRO MILLS LTD 84.43 22.28 1.34 1133.30 41.50 / 108.00
STANDARD INDUSTRIES LTD. 20.27 144.79 1.00 130.39 17.50 / 38.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 790.90 64.67 11.07 27760.59 574.70 / 1035.70
UTIQUE ENTERPRISES LIMITED 4.66 18.64 0.35 25.94 3.77 / 10.88
COMPUTER POINT LTD. 5.08 0.00 0.45 15.24 4.24 / 11.63
KOTHARI INDUSTRIAL CORPORATION 276.45 49.63 18.31 2147.57 3.82 / 276.45

Zenlabs Ethica Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
31.39 -3.97 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 32.20
  • 26 Days 32.10
  • 10 Days 32.30
  • 50 Days 32.80
  • 12 Days 32.20
  • 100 Days 34.60
  • 20 Days 32.10
  • 200 Days 37.10
32.66 PIVOT

First Support

31.03

First Resistance

34.33

Second Support

29.36

Second Resistance

35.96

Third Support

27.73

Third Resistance

37.63

RSI

52.05

ADX

10.09

MACD

0.16

Williams % R

-29.66

Commodity Channel Index (CCI)

63.10

Date

2025-04-29

Week

2600.00

Same Day

414.00

Month

3540.00

1 Year

0.66

3 Year

0.47

Over 1 Month

2.96%

down

Over 1 Year

-29.21%

down

Over 3 Months

-9.01%

down

Over 3 Years

-1.05%

down

Over 6 Months

-20.82%

down

Over 5 Years

1.73%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

Zenlabs Ethica Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
47.03%
Promoter Holdings
52.96%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Preet Remedies Limited 1730455.0 (26.58%) Shareholding of Promoter and Promoter Group
Sanjay Dhir 857728.0 (13.18%) Shareholding of Promoter and Promoter Group
Sanjeev Kumar Singal 857574.0 (13.17%) Shareholding of Promoter and Promoter Group
Hitesh Popatlal Oswal 441962.0 (6.79%) Public Shareholding
B S Mallikarjuna 142261.0 (2.19%) Public Shareholding
Bhasakarrai Kanyalal Bhatt 120945.0 (1.86%) Public Shareholding
Shyama Goyal 77714.0 (1.19%) Public Shareholding
Harjinder Kaur 1000.0 (0.02%) Shareholding of Promoter and Promoter Group
Himjyoti 1000.0 (0.02%) Shareholding of Promoter and Promoter Group
Daman Singhal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kulwant Kaur 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Zenlabs Ethica Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
29 Jul 2022 0.25 Interim 01 Aug 2022 Equity shares
20 Sep 2017 0.25 Final 22 Sep 2017 Equity shares
Ex-Date Ex-Bonus Ratio
13 Oct 2018 11 Oct 2018 1:20
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Zenlabs Ethica Limited Share Price

Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993. The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network. It deals into marketing and distribution of pharmaceutical products and has grown to be of India's top pharmaceutical companies in 2019.

The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada. The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people. Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.

In 2023, the Company has ventured into diversified segments like Neurology and Cytrics. It manufactures drugs for varied brands and sticks to international standards and prescribed norms. These drugs are marketed in factory packaging. As a WHO GMP certified company, the quality of each product is of highly advanced procurement & supply facility.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Zenlabs Ethica Ltd?

Answer Field

The share price of Zenlabs Ethica Ltd for NSE is ₹ 0.00 and for BSE is ₹ 31.39.

What is the Market Cap of Zenlabs Ethica Ltd?

Answer Field

The market cap of Zenlabs Ethica Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 20.40 Cr. as of now.

What is the 52 Week High and Low of Zenlabs Ethica Ltd?

Answer Field

The 52 Week High and Low of Zenlabs Ethica Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 52.40 and ₹ 27.33.

How to Buy Zenlabs Ethica Ltd share?

Answer Field

You can trade in Zenlabs Ethica Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Zenlabs Ethica Ltd?

Answer Field

The 1 year returns on the stock has been -31.46%.

What is the Current Share Price of Zenlabs Ethica Ltd?

Answer Field

Zenlabs Ethica Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 31.39 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Zenlabs Ethica Ltd Share?

Answer Field

The market cap of Zenlabs Ethica Ltd for NSE ₹ 0.0 & for BSE ₹ 20.40 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Zenlabs Ethica Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Zenlabs Ethica Ltd share is 61.55.

What is the PB ratio of Zenlabs Ethica Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Zenlabs Ethica Ltd share is 15.76.

How to Buy Zenlabs Ethica Ltd Share?

Answer Field

You can trade in Zenlabs Ethica Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zenlabs Ethica Ltd Share on Bajaj Broking App?

Answer Field

To buy Zenlabs Ethica Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zenlabs Ethica Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|